AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,925 Cr | ₹2,435 Cr | ₹2,387 Cr | ₹5,016 Cr | ₹3,329 Cr |
What is the latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹3,925 Cr |
| Mar2024 | ₹2,435 Cr |
| Mar2023 | ₹2,387 Cr |
| Mar2022 | ₹5,016 Cr |
| Mar2021 | ₹3,329 Cr |
How is Cash Flow from Operating Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,925 Cr | 61.21 | |
| Mar2024 | ₹2,435 Cr | 2.00 | |
| Mar2023 | ₹2,387 Cr | -52.42 | |
| Mar2022 | ₹5,016 Cr | 50.69 | |
| Mar2021 | ₹3,329 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹89,120.8 Cr | 3.8% | 7.9% | 41.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.8% |
7.9% |
41.9% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses